Sitting Tai Chi Program Benefits Subacute Stroke Survivors

THURSDAY, April 7, 2022 (HealthDay News) -- A tailored 12-week sitting tai chi program is beneficial for the recovery of subacute stroke survivors, according to a study published online April 7 in Stroke.
Jie Zhao, Ph.D., from the Yunnan University of Traditional Chinese Medicine in Kunming, and colleagues conducted a 12-week randomized controlled trial in China involving subacute stroke survivor-caregiver dyads. Eighty dyads were randomly assigned to the sitting tai chi group and 80 to an attention control group.
The researchers found that the sitting tai chi group (69 participants) showed significant upper-limb function improvement in the primary outcomes, including performance time and functional ability domains of the Wolf Motor Function test, balance control, and sitting balance control immediately postintervention. Improvements were also observed in secondary outcomes, including depressive symptoms, shoulder extension, activities of daily living, and quality of life compared with the control group (65 participants).
"Sitting tai chi uses minimal resources with assurance of safety and could meet the transitional care needs of stroke survivors," the authors write. "The current program, the inpatient training combined with video-guided self-practice, was beneficial to provide subacute stroke survivors and their caregivers with the knowledge and ability to exercise during their hospitalization to facilitate the continuation of their recovery after their return to the community."
Related Posts
Pollution Tied to Risk for Serious COVID-19 Despite Vaccination
FRIDAY, Oct. 7, 2022 (HealthDay News) -- Regardless of vaccination status,...
ASA: Endovascular Therapy Studied in Large Ischemic Stroke
THURSDAY, Feb. 16, 2022 (HealthDay News) -- Patients with large cerebral vessel...
Could Wireless Earbuds Help Boost Poor Hearing?
THURSDAY, Nov. 17, 2022 (HealthDay News) -- Over-the-counter hearing aids now...
There Might Be a Perfect Indoor Humidity to Curb COVID Spread
FRIDAY, Nov. 18, 2022 (HealthDay News) -- It’s sort of like the Goldilocks...
